Overview of Gatiquin P
Quick Facts
| Property | Description |
|---|---|
| Active Ingredients | Gatifloxacin and Prednisolone |
| Form | Topical Ophthalmic Suspension (Eye Drops) |
| Pharmacological Class | Fixed-Dose Combination (Anti-infective/Corticosteroid) |
| Origin | Synthetic |
| General Purpose | To address bacterial causes and related inflammation simultaneously |
Defining the Combined Action Medicine
Gatiquin P is a prescription-only fixed-dose combination (FDC) topical ophthalmic suspension, a type of sterile eye drop used to address the two primary components of certain eye conditions: microbial infection and subsequent inflammation. This medicinal entity is classified as an anti-infective and corticosteroid agent, utilizing two distinct synthetic active ingredients for targeted effect.
The FDC classification is a key identifying factor, meaning both therapeutic components are pre-measured and contained within a single bottle. This combination approach is clinically recognized for use in scenarios where simultaneous treatment of the bacterial cause and the resulting inflammatory reaction is required, thereby supporting its dual-action role as a synthetic pharmaceutical product.
Composition and General Purpose
The two core active ingredients are Gatifloxacin and Prednisolone. Gatifloxacin is categorized as a fluoroquinolone antibiotic, a class of anti-infectives that operates by interfering with essential bacterial enzymes to prevent cell division and replication. As a fourth-generation fluoroquinolone, it possesses a broad range of antimicrobial activity. This confirms the medicine's primary role is to eliminate the presence of bacterial pathogens. Prednisolone is classified as a potent glucocorticoid steroid. The general purpose of including this component is to rapidly suppress the localized inflammatory cascade. Ophthalmic steroids are characterized by anti-inflammatory and anti-oedematous properties, which help to mitigate symptoms like swelling and redness. This confirms the steroid component helps to quickly minimize the uncomfortable, damaging symptoms of inflammation and irritation. The overall general purpose is to achieve comprehensive dual-action relief by controlling the bacterial population and protecting sensitive ocular tissue from excessive inflammation.
Regulatory References
